108 related articles for article (PubMed ID: 8272416)
21. Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.
Cao X; Gibbs ST; Fang L; Miller HA; Landowski CP; Shin HC; Lennernas H; Zhong Y; Amidon GL; Yu LX; Sun D
Pharm Res; 2006 Aug; 23(8):1675-86. PubMed ID: 16841194
[TBL] [Abstract][Full Text] [Related]
22. Fed and fasted state gastro-intestinal in vitro lipolysis: In vitro in vivo relations of a conventional tablet, a SNEDDS and a solidified SNEDDS.
Christophersen PC; Christiansen ML; Holm R; Kristensen J; Jacobsen J; Abrahamsson B; Müllertz A
Eur J Pharm Sci; 2014 Jun; 57():232-9. PubMed ID: 24056027
[TBL] [Abstract][Full Text] [Related]
23. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
Latini R; Cerletti C; de Gaetano G; Dejana E; Galletti F; Urso R; Marzot M
Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):313-8. PubMed ID: 3733281
[TBL] [Abstract][Full Text] [Related]
24. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
[TBL] [Abstract][Full Text] [Related]
25. Absorption enhancement of rectally infused cefoxitin by medium chain monoglycerides in conscious rats.
Watanabe Y; van Hoogdalem EJ; de Boer AG; Breimer DD
J Pharm Sci; 1988 Oct; 77(10):847-9. PubMed ID: 3236226
[TBL] [Abstract][Full Text] [Related]
26. Physiological models are good tools to predict rat bioavailability of EF5154 prodrugs from in vitro intestinal parameters.
Nomoto M; Tatebayashi T; Morita J; Suzuki H; Aizawa K; Kurosawa T; Komiya I
J Pharm Sci; 2009 Apr; 98(4):1532-44. PubMed ID: 18683862
[TBL] [Abstract][Full Text] [Related]
27. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
Kambayashi A; Blume H; Dressman J
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
[TBL] [Abstract][Full Text] [Related]
28. [Biological availability of different oral cimetidine preparations in the dog].
Viernstein H; Plass H; Turnheim K
Arzneimittelforschung; 1990 Jun; 40(6):675-8. PubMed ID: 2397003
[TBL] [Abstract][Full Text] [Related]
29. Compaction of enteric-coated pellets: influence of formulation and process parameters on tablet properties and in vivo evaluation.
Debunne A; Vervaet C; Mangelings D; Remon JP
Eur J Pharm Sci; 2004 Jul; 22(4):305-14. PubMed ID: 15196587
[TBL] [Abstract][Full Text] [Related]
30. Investigation of the relationship between in vitro and in vivo release behaviors of acamprosate from enteric-coated tablets.
Rhee YS; Park S; Lee TW; Park CW; Nam TY; Oh TO; Jeon JW; Lee DS; Park ES
Arch Pharm Res; 2008 Jun; 31(6):798-804. PubMed ID: 18563364
[TBL] [Abstract][Full Text] [Related]
31. Design and in vivo evaluation of a patch system based on thiolated polymers.
Hoyer H; Greindl M; Bernkop-Schnürch A
J Pharm Sci; 2009 Feb; 98(2):620-7. PubMed ID: 18661531
[TBL] [Abstract][Full Text] [Related]
32. Preparation and evaluation of a novel gastric mucoadhesive sustained-release acyclovir microsphere.
Liu H; Pan W; Ke P; Dong Y; Ji L
Drug Dev Ind Pharm; 2010 Sep; 36(9):1098-105. PubMed ID: 20545521
[TBL] [Abstract][Full Text] [Related]
33. ColoPulse tablets perform comparably in healthy volunteers and Crohn's patients and show no influence of food and time of food intake on bioavailability.
Maurer JM; Schellekens RC; van Rieke HM; Stellaard F; Wutzke KD; Buurman DJ; Dijkstra G; Woerdenbag HJ; Frijlink HW; Kosterink JG
J Control Release; 2013 Dec; 172(3):618-24. PubMed ID: 24096020
[TBL] [Abstract][Full Text] [Related]
34. Improved oral absorption of L-365,260, a poorly soluble drug.
Lin JH; Storey DE; Chen IW; Xu X
Biopharm Drug Dispos; 1996 Jan; 17(1):1-15. PubMed ID: 8991487
[TBL] [Abstract][Full Text] [Related]
35. Bioavailability of enteric-coated sodium fluoride tablets as affected by the administration of calcium supplements at different time intervals.
Devogelaer JP; Nagant de Deuxchaisnes C; Stein F
J Bone Miner Res; 1990 Mar; 5 Suppl 1():S75-9. PubMed ID: 2339640
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Glucosamine Absorption After Administration of Oral Liquid, Chewable, and Tablet Formulations to Dogs.
Maxwell LK; Regier P; Achanta S
J Am Anim Hosp Assoc; 2016; 52(2):90-4. PubMed ID: 26808433
[TBL] [Abstract][Full Text] [Related]
37. Radiotelemetric method for evaluating enteric coatings in vivo.
Dressman JB; Amidon GL
J Pharm Sci; 1984 Jul; 73(7):935-8. PubMed ID: 6470956
[TBL] [Abstract][Full Text] [Related]
38. Improvement of bioavailability of poorly absorbed drugs. II. Effect of medium chain glyceride base on the intestinal absorption of cefmetazole sodium in rats and dogs.
Sekine M; Terashima H; Sasahara K; Nishimura K; Okada R; Awazu S
J Pharmacobiodyn; 1985 Apr; 8(4):286-95. PubMed ID: 3861846
[TBL] [Abstract][Full Text] [Related]
39. Bioavailability of different forms of amoxycillin administered orally to dogs.
Küng K; Wanner M
Vet Rec; 1994 Dec; 135(23):552-4. PubMed ID: 7886889
[TBL] [Abstract][Full Text] [Related]
40. Variable effects of laurocapram (Azone) on rectal cefoxitin absorption in rats.
van Hoogdalem EJ; de Best MA; de Boer AG; Breimer DD
J Pharm Sci; 1989 Aug; 78(8):691-2. PubMed ID: 2778677
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
